platinum-resistant ovarian cancer

ImmunoGen’s drug Elahere offers hope for ovarian cancer patients
ImmunoGen’s drug Elahere offers hope for ovarian cancer patients
Clinical Trials Arena
Immunogen
Elahere
clinical trials
platinum-resistant ovarian cancer
ovarian cancer
Flag link:
ImmunoGen reports positive top-line data from ovarian cancer therapy trial
ImmunoGen reports positive top-line data from ovarian cancer therapy trial
Clinical Trials Arena
Immunogen
clinical trial
ovarian cancer
platinum-resistant ovarian cancer
Elahere
Flag link:
OncoC4 doses first participant in ovarian cancer therapy trial
OncoC4 doses first participant in ovarian cancer therapy trial
Clinical Trials Arena
OncoC4
clinical trials
ONC-392
Merck
Keytruda
ovarian cancer
platinum-resistant ovarian cancer
Flag link:
Compugen COM701 in dual/triple combo shows promise in ovarian cancer patients in trial
Compugen COM701 in dual/triple combo shows promise in ovarian cancer patients in trial
Seeking Alpha
CompuGen
COM701
Bristol Myers Squibb
Opdivo
ovarian cancer
platinum-resistant ovarian cancer
Flag link:
Novocure launches pivotal ovarian cancer trial
Novocure launches pivotal ovarian cancer trial
Drug Delivery Business News
Novocure
devices
ovarian cancer
platinum-resistant ovarian cancer
clinical trials
tumor treating fields
Flag link:
Aravive Biologics’ Treatment For Platinum-Resistant Recurrent Ovarian Cancer Receives Fast Track Designation
Aravive Biologics’ Treatment For Platinum-Resistant Recurrent Ovarian Cancer Receives Fast Track Designation
CP Wire
Aravive Biologics
AVB-S6-500
ovarian cancer
platinum-resistant ovarian cancer
Flag link:
Aravive Biologics’ Treatment For Platinum-Resistant Recurrent Ovarian Cancer Receives Fast Track Designation
Aravive Biologics
AVB-S6-500
ovarian cancer
platinum-resistant ovarian cancer
Flag link:
ImmunoGen Gets Good News From Interim Analysis of Mirvetuximab Soravtansine in Platinum-Resistant Ovarian Cancer
ImmunoGen Gets Good News From Interim Analysis of Mirvetuximab Soravtansine in Platinum-Resistant Ovarian Cancer
CP Wire
Immunogen
mirvetuximab soravtansine
ovarian cancer
platinum-resistant ovarian cancer
Flag link:
ImmunoGen Gets Good News From Interim Analysis of Mirvetuximab Soravtansine in Platinum-Resistant Ovarian Cancer
Immunogen
mirvetuximab soravtansine
ovarian cancer
platinum-resistant ovarian cancer
Flag link:
Preliminary positive results for Phase I - II trial of Tesaro's Zejula with Keytruda in platinum-resistant ovarian cancer (TSRO)
Preliminary positive results for Phase I - II trial of Tesaro's Zejula with Keytruda in platinum-resistant ovarian cancer (TSRO)
CP Wire
Tesaro
Zejula
Merck
Keytruda
platinum-resistant ovarian cancer
niraparib
clinical trials vaccines
Flag link:
Preliminary positive results for Phase I - II trial of Tesaro's Zejula with Keytruda in platinum-resistant ovarian cancer
Tesaro
Zejula
Merck
Keytruda
platinum-resistant ovarian cancer
niraparib
clinical trials
Flag link:
Oxigene Receives Fast Track Designation From U.S. FDA for CA4P
Oxigene Receives Fast Track Designation From U.S. FDA for CA4P
Yahoo
Oxigene
fast track
FDA
CA4P
ovarian cancer
platinum-resistant ovarian cancer
Flag link: